Energy 90.5 Top Music Radio
The US Food and Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label, making it the first weight-loss drug to also be cleared to reduce the risk of heart attack, stroke or heart-related death in people at higher risk of these conditions. Read More Breaking News, Latest News and Videos | CNN
Copyright © 2025. All Rights Reserved.Chole Broadcasting